Responses
Scientific Abstracts
Abstracts Accepted for Publication
Scleroderma, myositis and related syndromes
AB0626 IMATINIB FOR THE TREATMENT OF SYSTEMIC SCLEROSIS: RATIONALE, CLINICAL EVIDENCE AND FUTURE DEVELOPMENT
Compose a Response to This Article
Other responses
No responses have been published for this article.